Back to Library
Urgent Referral

Fetal Therapy & Procedures

Intrauterine Transfusion (IUT)

Reviewed by: Dr. Ali Al-Ibrahim
10 min read
Last reviewed: 2026-06-07
Umbilical VeinTarget
30-45 MinutesProcedure Time
>95%Success Rate
O-NegativeBlood Type

In brief — the direct answer

Intrauterine Transfusion (IUT) is a highly specialized fetal therapy used to treat severe fetal anaemia. Whether the anaemia is caused by Rh incompatibility (blood group mismatch) or a viral infection (like Parvovirus), giving the baby healthy red blood cells can prevent heart failure and allow the pregnancy to continue until the baby is mature enough to be born. Performed under continuous ultrasound guidance, IUT is one of the most established and successful forms of 'surgery' in modern fetal medicine.

What is Intrauterine Transfusion (IUT)?

The procedure involves passing a fine needle through the mother's abdomen and into the baby's umbilical cord, specifically the umbilical vein.

Before the procedure, our laboratory prepares a unit of 'O-negative' blood that has been cross-matched with the mother's blood, irradiated (to prevent immune reactions), and 'packed' so that a small volume provides a high concentration of red blood cells. This ensures we don't 'overload' the baby's heart while still giving them enough blood to thrive.

Who is at risk?

IUT is indicated when non-invasive monitoring (MCA Doppler) shows that the baby is significantly anaemic. Without this procedure, severely anaemic babies can develop Hydrops Fetalis (fluid buildup) and may not survive. The procedure can be performed as early as 16-18 weeks of pregnancy and as late as 35 weeks.

How we diagnose it

Before the needle is inserted, we perform a 'Final Check':

  1. Doppler Mapping: Locating the best entry point into the umbilical cord (usually where it attaches to the placenta).
  2. Hemoglobin Calculation: Based on the baby's gestation and the current MCA Doppler speed, we calculate the exact volume of blood the baby needs (usually between 30ml and 100ml).
  3. Fetal Positioning: Ensuring the baby is in a stable position, sometimes using a temporary muscle relaxant for the baby so they don't move during the needle placement.

What does management involve?

The procedure follows a precise sequence:

  • Access: Under local anesthesia for the mother, the needle is guided into the umbilical vein.
  • Blood Sampling: First, a small sample of the baby's blood is taken to confirm the exact hemoglobin level (Cordocentesis).
  • The Transfusion: The prepared blood is slowly pushed through the needle manually by the surgeon. We watch the baby's heart rate continuously on the monitor.
  • Post-Care: We take a final sample to confirm the new, healthy blood level. The needle is then removed, and the mother is monitored for 4-6 hours in our recovery suite.

What are the outcomes?

The medical success of IUT is outstanding.

  • Recovery: Within 24-48 hours, the baby's heart function often improves, and their movement increases.
  • Resolution of Hydrops: If the baby had fluid buildup, it usually begins to disappear within a week of the first transfusion.
  • Birth: Most babies who receive IUTs are born healthy at 34-36 weeks. They may have jaundice (yellow skin) after birth, but this is easily treated with blue-light therapy (phototherapy) in the NICU.

When to see a subspecialist

IUT is a high-precision procedure that should only be performed at a tertiary fetal medicine center with specialized pediatric blood-banking facilities.

Our team, led by Dr. Ali Al-Ibrahim, is the regional lead for intrauterine transfusions. We manage the most complex cases of red-cell and platelet alloimmunization, providing a safe and compassionate roadmap for families facing these high-stakes challenges.

Questions to ask your doctor

The baby may feel a tiny pinch, but we often give the baby a small dose of medication to keep them still and comfortable during the 30-minute procedure.
Usually, a baby needs a transfusion every 2 to 4 weeks. As the baby grows, their body needs more blood, and the transfused cells eventually wear out, requiring a top-up.
No. The blood we use is O-negative and specially 'washed' and 'filtered' so that neither the mother's nor the baby's immune system reacts to it.
The risk of a complication (like early delivery or infection) is about 1-2%. In the context of severe anaemia, which is otherwise life-threatening, IUT is considered very safe.
Dr. Ali Al-Ibrahim
Content Reviewer

Dr. Ali Al-Ibrahim

Head of Unit, Consultant Maternal Fetal Medicine

Consultant in Maternal-Fetal Medicine in Al Ain and Abu Dhabi with more than 25 years of experience, University of Toronto fellowship training, and Arab and Saudi Board certification in OBGYN.

View Full Profile

References & Clinical Guidelines

  1. The Management of Women with Red Cell Antibodies during Pregnancy (Green-top Guideline No. 65) — RCOG (2014)
  2. Management of Alloimmunization During Pregnancy (Practice Bulletin 192) — ACOG (2018)
  3. ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis (fetal blood sampling / transfusion) — ISUOG (2016)
Share this resource